New DAPA-CKD Analysis Hints at Dapagliflozin for IgA Nephropathy ...Middle East

Medscape - News
The landmark DAPA-CKD trial showed that dapagliflozin slows CKD progression regardless of diabetes status. Now a prespecified analysis suggests it also works for CKD patients with an IgA etiology. Medscape Medical News

Hence then, the article about new dapa ckd analysis hints at dapagliflozin for iga nephropathy was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New DAPA-CKD Analysis Hints at Dapagliflozin for IgA Nephropathy )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News